Integrated Net Receivables from 2010 to 2024
| IDHC Stock | 0.40 0.02 5.26% |
Net Receivables | First Reported 2012-12-31 | Previous Quarter 705 M | Current Value 754.7 M | Quarterly Volatility 193.7 M |
Check Integrated Diagnostics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Integrated Diagnostics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 421.3 M, Selling General Administrative of 168.1 M or Selling And Marketing Expenses of 92 M, as well as many indicators such as . Integrated financial statements analysis is a perfect complement when working with Integrated Diagnostics Valuation or Volatility modules.
Integrated | Net Receivables |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Integrated Stock Analysis
When running Integrated Diagnostics' price analysis, check to measure Integrated Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Integrated Diagnostics is operating at the current time. Most of Integrated Diagnostics' value examination focuses on studying past and present price action to predict the probability of Integrated Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Integrated Diagnostics' price. Additionally, you may evaluate how the addition of Integrated Diagnostics to your portfolios can decrease your overall portfolio volatility.